ProQuant™ is now offered by RxCelerate following the acquisition of the proteomics team from Methuselah Health in 2022. Methuselah Health was founded in 2015 to discover drugs for age-related diseases driven by proteomic instability, and has developed the world’s most powerful proteomics platform to power its discovery efforts. RxCelerate was founded in 2013 with a vision to provide a bespoke high-quality outsourced drug discovery and development platform. Originally focused on delivering preclinical and in vitro biology services, during the last nine years we have expanded our in-house capabilities to include chemistry, in silico design, systems biology and project and programme management.
World leading proteomics platform
ProQuant™ is a world-leading proprietary platform for performing LC-MS/MS bottom-up proteomics on a wide range of biological samples, delivering precision unachievable by other proteomics platforms.
Learn more about our proprietary technology.